Ortona L, Pizzigallo E, Federico G, Camilli G
Arch Sci Med (Torino). 1979 Oct-Dec;136(4):509-22.
A radioimmunological assay was made of HBsAg and HBsAb in 183 patients during the course of acute viral hepatitis, 23 with prior HBsAg-positive hepatitis, 72 with chronic liver disease, 822 blood donors, 44 patients and 28 staff members from two dialysis centres, and the medical and paramedical staff of several high-risk departments. Microimmunodiffusion on agar was also used to determine HBeAg and HBeAb in the same 183 acute hepatitis patients, 37 HBsAg+ blood donors, 20 asymptomatic HBsAg carriers, the patients of two haemodialysis centres and the staff of departments at high risk for hepatitis B. Attention is drawn to the marked incidence (5.5%) of chronic HBsAg carriers in the blood donors, and the considerable circulation of virus B in the population examined, HBsAb-positivity (27.6%) being also an expression of this. Stress is also laid on the diagnostic and prognostic significance of the study of the HBsAg-HBsAb system during acute and chronic hepatitis. The importance of serum hepatitis B markers in the transmission of this disease in dialysis centres and other high-risk departments and in its prevention is underscored. Lastly, emphasis is laid on the appreciable progress that analysis of the e-anti-e system offers in the prognostic assessment of type B hepatitis, attention being also drawn to the fact that the dynamics of this system is even more complex and interesting than had first been thought. An assessment of this kind is useful in the differentiation of "contagious" and "non-contagious" HBsAg carriers.
对183例急性病毒性肝炎患者、23例曾患乙肝表面抗原阳性肝炎的患者、72例慢性肝病患者、822名献血者、两个透析中心的44例患者和28名工作人员以及几个高风险科室的医护人员进行了乙肝表面抗原(HBsAg)和乙肝表面抗体(HBsAb)的放射免疫分析。还采用琼脂微量免疫扩散法对同样的183例急性肝炎患者、37例乙肝表面抗原阳性献血者、20例无症状乙肝表面抗原携带者、两个血液透析中心的患者以及乙肝高风险科室的工作人员检测乙肝e抗原(HBeAg)和乙肝e抗体(HBeAb)。值得注意的是,献血者中慢性乙肝表面抗原携带者的发生率较高(5.5%),在所检测人群中乙肝病毒大量传播,乙肝表面抗体阳性率(27.6%)也表明了这一点。同时强调了在急慢性肝炎期间研究乙肝表面抗原 - 乙肝表面抗体系统的诊断和预后意义。强调了血清乙肝标志物在透析中心和其他高风险科室该疾病传播及预防中的重要性。最后,强调了e抗原 - e抗体系统分析在乙肝预后评估方面取得的显著进展,还指出该系统的动态变化比最初认为的更为复杂和有趣。这种评估有助于区分“传染性”和“非传染性”乙肝表面抗原携带者。